Community prevalence of advanced liver fibrosis in Type 2 diabetes—How big is the challenge?

Kushala W.M. Abeysekera; Paul N. Brennan

doi:10.1111/joim.20113

Community prevalence of advanced liver fibrosis in Type 2 diabetes—How big is the challenge?

Kushala W.M. Abeysekera
, Paul N. Brennan

Respiratory Medicine and Gastroenterology

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	152-154
Number of pages	3
Journal	Journal of Internal Medicine
Volume	298
Issue number	3
Early online date	30 Jun 2025
DOIs	https://doi.org/10.1111/joim.20113
Publication status	Published - 23 Aug 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.1111/joim.20113

Cite this

@article{cdefee04566b4fc09c0699163c813ee9,

title = "Community prevalence of advanced liver fibrosis in Type 2 diabetes—How big is the challenge?",

author = "Abeysekera, \{Kushala W.M.\} and Brennan, \{Paul N.\}",

year = "2025",

month = aug,

day = "23",

doi = "10.1111/joim.20113",

language = "English",

volume = "298",

pages = "152--154",

journal = "Journal of Internal Medicine",

issn = "0954-6820",